Verzenio: Data from P3 MONARCH-2 trial (NCT02107703) in HER2- breast cancer at ESMO (September 27 - October 1, 2019) (Eli Lilly) - Sep 10, 2019 - World Lung: Data from P2 monarcHER trial (NCT02675231) in metastatic breast cancer at ESMO (September 27 - October 1, 2019)
P2 data • P3 data
|